Healthcare >> Analyst Interviews >> June 23, 2008

DIRECT-ACTING ANTIVIRALS & HEPATITIS C

TWST: Liisa, where do you focus your attention in biotech?

Ms. Bayko: Right now I'm focused on infectious disease and specifically I've

done quite a bit of work in the hepatitis C area. So